Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05997875 · ClinicalTrials.gov registry record · NA
Transforming Hemodialysis-Related Vascular Access Education
A NA study of Chronic Kidney Disease and Hemodialysis Vascular Access, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 2
- Study locations
NCT05997875: Recruiting NA study of Chronic Kidney Disease and Hemodialysis Vascular Access, sponsored by University of Pennsylvania.
NCT05997875 is a NA study of Chronic Kidney Disease and Hemodialysis Vascular Access that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 360 participants, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05997875, a NA study of Chronic Kidney Disease and Hemodialysis Vascular Access, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 2
- Study locations
Study Summary
The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 approaches: 1) "Education", in which participants will be given a video and brochure that provide information about the types of vascular access and what can be expected before and after the vascular access is placed, 2) "Education-Plus", in which participants will be given the video and brochure and will also have sessions by telehealth with a motivational interviewing coach to provide additional support around vascular access placement, and 3) "Usual Care", in which participants will have the usual education provided by their kidney doctor and clinic staff just as if they were not in the study. Participants in all 3 groups will be asked to complete questionnaires by telephone and may be invited to be interviewed about their experience with the study intervention at the end of the study. Study participation will last for about 12 months, with most of the study activities taking place during the first 3 months.
Primary Outcome
The proportion of participants who have arteriovenous access creation surgery.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Educational Materials
- OTHER Patient Lists for Clinicians: System-Level Intervention
Study Locations (2)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2023-12-05 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT05997875 shows while recruiting
NCT05997875 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.
NCT05997875 reports a single indexed study location in North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05997875 about?
NCT05997875 is a clinical study titled "Transforming Hemodialysis-Related Vascular Access Education". The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 a...
What is the current status of trial NCT05997875?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2023-12-05. Estimated completion is 2027-09-30.
What conditions does trial NCT05997875 study?
This clinical trial studies the following conditions: Chronic Kidney Disease, Hemodialysis Vascular Access.
What interventions are being tested in trial NCT05997875?
The interventions under investigation include: Usual Care (BEHAVIORAL), Motivational Interviewing (BEHAVIORAL), Educational Materials (BEHAVIORAL), Patient Lists for Clinicians: System-Level Intervention (OTHER).
Who is sponsoring clinical trial NCT05997875?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05997875 being conducted?
This trial has 2 study locations across North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05997875's enrollment target sits among peer trials
360 30th of 101 higher than 72 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
-
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
RECRUITING · NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
-
Dine and DASH Into Wellness Pilot Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI